Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

Market Cap	11.26B +1.6%
Revenue (ttm)	6.58B +1.8%
Net Income	687.99M +41.3%
EPS	0.27 +42.9%
Shares Out	2.54B
PE Ratio	16.25
Forward PE	n/a
Dividend	0.15 (3.40%)
Ex-Dividend Date	Jun 25, 2025

Volume	45,846,853
Average Volume	39,468,249
Open	4.430
Previous Close	4.410
Day's Range	4.400 - 4.480
52-Week Range	4.040 - 4.900
Beta	0.30
RSI	51.27
Earnings Date	Apr 23, 2026

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In additio...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 8,411
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600572

Financial Performance

In 2024, SHA:600572's revenue was 6.52 billion, a decrease of -3.23% compared to the previous year's 6.73 billion. Earnings were 622.42 million, an increase of 5.21%.